NCT05614635

Brief Summary

The aim of this study is to gather clinical data related to the use of Plastalgin and Plastalgin Fast, in order to comply with the new medical device regulation. The target population for this study is the same as the intended population specified in the study device's instructions for use: children from 5 years old and adults. Collection, recording, and reporting of data will be accurate and will ensure the privacy, health, and welfare of participating patients during and after the study

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2022

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 12, 2022

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

October 24, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

November 14, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 7, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 7, 2023

Completed
Last Updated

April 24, 2023

Status Verified

April 1, 2023

Enrollment Period

5 months

First QC Date

October 24, 2022

Last Update Submit

April 21, 2023

Conditions

Keywords

Fabrication of prosthesisAlginate Dental Impression

Outcome Measures

Primary Outcomes (1)

  • Anatomical reproductibility of the dental impression with Plastalgin and Plastalgin Fast.

    Dentist's opinion through a questionnaire completed by the dentist

    Immediately after the procedure.

Secondary Outcomes (4)

  • Number of impressions needed per patient

    Immediately after the procedure.

  • Setting time of Plastalgin and Plastalgin Fast

    During the procedure.

  • Rate of adverse events

    During and immediately after the procedure.

  • Rate of device-related adverse event

    During and immediately after the procedure.

Interventions

Plastalgin and Plastalgin Fast are potassium alginate-based powders designed for dental impression. The powder is mixed with water to obtain an impression material paste, used to imprint the teeth and mouth of the patient. The product is available under two presentations: Plastalgin and Plastalgin Fast. Plastalgin Fast has a shorter mixing time.

Eligibility Criteria

Age5 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The target population for this study is the same as the intended population specified in the study device's instructions for use: children from 5 years old and adults. Minors are eligible to participate in the study. Other vulnerable patients can be included in the study as there is no additional risk for this population.

You may qualify if:

  • Patient fulfilling all the following criteria is eligible for the clinical investigation:
  • Male or female patient ≥ 5 years of age.
  • Indication of dental impressions for the fabrication of prosthesis such as mouth guards and trays, total or partial dentures, and fixed prosthesis (crowns, bridges, dental veneers).
  • Total or partially edentulous patient or patient with disocclusion or patient with misalignment.
  • Patient affiliated or beneficiary of a social security system.
  • Written informed consent must be obtained before any study-related assessment is performed.

You may not qualify if:

  • Inability to comply with study procedures.
  • Patient opposing the processing of their data.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Cabinet dentaire

Montigny-le-Bretonneux, 78180, France

Location

Cabinet dentaire

Paris, 75011, France

Location

MeSH Terms

Conditions

MalocclusionMouth, Edentulous

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic DiseasesMouth Diseases

Study Officials

  • Stephanie INDUNI, MD

    Cabinet dentaire

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 24, 2022

First Posted

November 14, 2022

Study Start

October 12, 2022

Primary Completion

March 7, 2023

Study Completion

March 7, 2023

Last Updated

April 24, 2023

Record last verified: 2023-04

Locations